Impact of Exosomes Released by Different Corneal Cell Types on the Wound Healing Properties of Human Corneal Epithelial Cells
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.
Abstract
Corneal wound healing involves communication between the different cell types that constitute the three cellular layers of the cornea (epithelium, stroma and endothelium), a process ensured in part by a category of extracellular vesicles called exosomes. In the present study, we isolated exosomes released by primary cultured human corneal epithelial cells (hCECs), corneal fibroblasts (hCFs) and corneal endothelial cells (hCEnCs) and determined whether they have wound healing characteristics of their own and to which point they modify the genetic and proteomic pattern of these cell types. Exosomes released by all three cell types significantly accelerated wound closure of scratch-wounded hCECs in vitro compared to controls (without exosomes). Profiling of activated kinases revealed that exosomes from human corneal cells caused the activation of signal transduction mediators that belong to the HSP27, STAT, β-catenin, GSK-3β and p38 pathways. Most of all, data from gene profiling analyses indicated that exosomes, irrespective of their cellular origin, alter a restricted subset of genes that are completely different between each targeted cell type (hCECs, hCFS, hCEnCs). Analysis of the genes specifically differentially regulated for a given cell-type in the microarray data using the Ingenuity Pathway Analysis (IPA) software revealed that the mean gene expression profile of hCECs cultured in the presence of exosomes would likely promote cell proliferation and migration whereas it would reduce differentiation when compared to control cells. Collectively, our findings represent a conceptual advance in understanding the mechanisms of corneal wound repair that may ultimately open new avenues for the development of novel therapeutic approaches to improve closure of corneal wounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Thus, exosomes are produced by almost all cell types [21,22,23,24,25,26].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 1×
“Their round morphology (often with a central depression) and sizes are well-established features of such small extracellular vesicles [50].”
BackgroundExtracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · cited 1×
“Results indicate that exosomes’ diameters vary from 67 to 135 nm between the three corneal cell types, which correspond to the typical range of sizes for exosomes as observed in the literature [51,52].”
BackgroundIsolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346 · cited 1×
“Traditionally, several members of this family, especially CD63, CD9 and CD81 were known to be highly enriched in exosomes from virtually any cell type and are commonly used as markers for exosomes identification, quantitation, or purification [75], although irregularities in their respective expression has recently be…”
BackgroundLötvall, J., Hill, A. F., Hochberg, F., Buzás, E. I., Di Vizio, D., Gardiner, C., Gho, Y. S., Kurochkin, I. V., Mathivanan, S., Quesenberry, P., et al. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.26913 · Cited by 2,451 · cited 8×
“In our present study, all three exosome markers were found to be expressed by hCECs and hCFs exosomes but not by hCEnCs that were positive for CD63 and CD9 but not for CD81.”
BackgroundInfluentialControl of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009 · cited 1×
“Furthermore, because they can carry various molecules, exosomes are now being tested as drug carriers to treat diseases such as Parkinson disease [36], pancreatic cancers [37] and lung diseases [38].”
BackgroundTetraspanins in Extracellular Vesicle Formation and Function
Andreu, Z., & Yáñez-Mó, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00442 · Cited by 1,487 · cited 1×
“However, these types of tetraspanins have also been identified in other types of EVs, which highlights the complexity of finding a unique exosomal marker [77].”
BackgroundEV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
EV-TRACK Consortium, Van Deun, J., Mestdagh, P., Agostinis, P., Akay, Ö., Anand, S., Anckaert, J., Martinez, Z. A., Baetens, T., Beghein, E., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4185 · Cited by 1,284
Cited by
Mechanistic investigations of diabetic ocular surface diseases
Zhou, Q., Yang, L., Wang, Q., Li, Y., Wei, C., & Xie, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1079541 · Cited by 92
Verma, N., Khare, D., Poe, A. J., Amador, C., Ghiam, S., Fealy, A. W., Ebrahimi, S. M., Shadrokh, O., Song, X., Santiskulvong, C., et al. (2023) · Cells · doi:10.3390/cells12212524 · Cited by 44
Verma, N., Arora, S., Singh, A. K., & Kumar, A. (2025) · Targets · doi:10.3390/targets3040032 · Cited by 37
“Within the cornea, exosomes orchestrate processes including wound healing, angiogenesis, lymphangiogenesis, and nerve repair by activating signaling pathways such as HSP27, STAT, and β -catenin to accelerate epithelial closure and promote cell migration and proliferation [14,15].”
Cell therapy in the cornea: The emerging role of microenvironment
Suanno, G., Genna, V. G., Maurizi, E., Abu‐Dieh, A., Griffith, M., & Ferrari, G. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101275 · Cited by 32
Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications
Volatier, T. L. A., Cursiefen, C., & Notara, M. (2024) · Cells · doi:10.3390/cells13020163 · Cited by 26
“This change is linked to the process of epithelial-to-mesenchymal transition [100].”
BackgroundCorneal Treatment, Repair, and Regeneration: Exosomes at Rescue
Robbins, B. T., Montreuil, K. A., Kundu, N., Kumar, P., & Agrahari, V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111424 · Cited by 19
“7 of 21 The uptake of exosomes enriched with Human corneal epithelial cells (hCECs), corneal fi bro-blasts (hCFs), corneal endothelial cells (hCEnCs) was monitored [27]. as alternatives to surgical corneal transplants.”
InfluentialWang, M., Yang, X., Ye, Y., Fan, K., Chen, C., Zheng, L., Li, X., Dong, C., Li, C., & Dong, N. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124784 · Cited by 13
Khorrami‐Nejad, M., Hashemian, H., Majdi, A., Jadidi, K., Aghamollaei, H., & Hadi, A. (2025) · The Ocular Surface · doi:10.1016/j.jtos.2025.01.012 · Cited by 13
Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases
Gamez, J., Zha, D., Ebrahimi, S. M., White, S. V., Ljubimov, A. V., & Saghizadeh, M. (2025) · Cells · doi:10.3390/cells14130959 · Cited by 14
“…in mouse cornea [95] Human CECs, corneal fibroblasts, and endothelial cells Human in vitro Induced wound closure and proliferation in human CECs [97] Human in vitro Enhanced proliferation and migration of primary human LECs in dry eye disease model (high osmotic stress) [99] Mouse in vitro…”
Tati, V., Sai, S. S. S., & Shukla, S. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110027 · Cited by 15
Extracellular vesicles as reconfigurable therapeutics for eye diseases: Promises and hurdles
Shekari, F., Abyadeh, M., Meyfour, A., Mirzaei, M., Chitranshi, N., Gupta, V., Graham, S. L., & Salekdeh, G. H. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102437 · Cited by 11
García-Posadas, L., Romero‐Castillo, I., Brennan, K., Gee, M. M. M., Blanco, A., & Diebold, Y. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.12.38 · Cited by 9
“13,14,31,32 Those studies also highlight that the basement membrane appears to limit EV diffusion, what could mean that the impact of EVs released by stromal cells may depend on the basement membrane integrity.”
Proteomic Insights into Human Limbal Epithelial Progenitor-Derived Small Extracellular Vesicles
Braunsperger, M. V., Martin, G., Herzig, T., Kußberger, I., Gießl, A., Steimle, S., Schlötzer-Schrehardt, U. M., Schlunck, G., Reinhard, T., & Polisetti, N. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10877-w · Cited by 9
Iswarya, R., Subbaiah, K., Dharmalingam, K., & Priya, C. G. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110281 · Cited by 8
Exosomal microRNAs as potential biomarkers and therapeutic targets in corneal diseases.
Arora, S., & Verma, N. (2024) · PubMed Central · Cited by 7
RetractedScientometric analysis of extracellular vesicles in vision science (up to 2024)
Liao, F., Germaín, F., Ma, L., Wei, C., & Wang, T. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03703-5 · Cited by 6
Corneal epithelial-stromal constructs to study differences associated with diabetes mellitus
Hefley, B. S., McKay, T. B., Hutcheon, A. E. K., Ciolino, J. B., & Karamichos, D. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110100 · Cited by 6
Mäkinen, P., Nättinen, J. E., Aapola, U., Pietilä, J., & Uusitalo, H. M. T. (2024) · Clinical Proteomics · doi:10.1186/s12014-024-09460-1 · Cited by 4
“HSPB1 responds to environmental stress and has an important role in corneal epithelial protection and wound healing [34, 35].”
BackgroundSmall Extracellular Vesicle–Mediated Peptide Delivery to the Mouse Corneal Endothelium In Vivo
Lee, J., Lee, S.-Y., Pollalis, D., & Heur, M. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.100900 · Cited by 2
“27,28 Small EVs derived from adipose tissue — derived mesenchymal stem cells have demonstrated the ability to promote wound healing and regeneration by inducing cell cycle progression in human corneal endothelial cells (hCECs).”
Rosenquist, J., de Ven, A. V., Braesch-Andersen, K., Juriga, D., Norein, N., Hansson, P., & Samanta, A. (2025) · ACS Omega · doi:10.1021/acsomega.5c01135 · Cited by 4
Extracellular Vesicles of Tears and Ocular Surface: An Enigma
Fatima, A., Attem, J., Esam, S., & Vemuganti, G. K. (2025) · Current Eye Research · doi:10.1080/02713683.2025.2503214 · Cited by 6
“Recently, Desjardins et al. 46 isolated sEVs from cultured human corneal epithelial, stromal fibroblasts and endothelial cells and found that the sEVs isolated from different corneal layers not only showed a difference in their EV markers but also the uptake of epithelial sEVs by the cells.”
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
Exosomes in corneal diseases: advances in diagnosis and therapy
Liao, X., Gao, H., Bai, M., Chi, W., & Yang, W. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1837531 · Cited by 2
“…repair by activating distinct signaling pathways. hCECs-Exos effectively promote cell migration and proliferation by activating the STAT3, p38 α (MAPK), and β -catenin pathways, along with STAT3/HSP27/ p38 α /Akt and GSK-3 β / β -catenin signaling axes (Desjardins et al., 2022; McKay et al., 2020).”
Exosomes in Corneal Homeostasis and Wound Healing
Hernandez, B. J., & Robertson, D. M. (2025) · Current Eye Research · doi:10.1080/02713683.2025.2459335 · Cited by 4
“4 There has been a significant focus on the role of exosomal miRNAs and how they are altered during disease and injury.”
InfluentialRosenquist, J., de Ven, A. V., Braesch-Andersen, K., Juriga, D., Norein, N., Hansson, P., & Samanta, A. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-k8g8t · Cited by 2
Endogenous Therapeutic Agents for Acute Corneal and Ocular Surface Injuries
Reinhardt, C., Ong, J., Son, K., & Aakalu, V. K. (2026) · Translational Vision Science & Technology · doi:10.1167/tvst.15.3.16 · Cited by 1
“18 Another study examined mesenchymal stem cell exosomes (MSC-exo) and found MSC-exo treatment induced faster wound closure and more rapid cell proliferation and migration using an in vitro scratch assay.”
The Therapeutic Potential of Exosomes in Ocular Surface Diseases
Hu, L., Duan, H., Zhang, Y., Yang, L., Yoon, K. C., Zihan, S. H. E. N., Zekai, L. I., Ma, B., & Qi, H. (2026) · Biomolecules · doi:10.3390/biom16040512 · Cited by 4
RAJAK, S. K., Mohapatra, S., Singh, D., Joshi, V. P., Singh, V., & Basu, S. (2026) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2026.06.042 · Cited by 1
Ahmadi, S., Gohari-Lasaki, S., Jahangiri, N., Ejlalidiz, M., & Saberiyan, M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10642-9 · Cited by 1
Tayebi, T., Kasravi, M., Naderi, A., Nooshin, B. J., & Niknejad, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144744
Cruz, D. M. S., Cantero, M. J., Fiore, E. J., & Pacienza, N. (2025) · Oftalmología clínica y experimental. · doi:10.70313/2718.7446.v18.n2.421
Chen, H.-C., Hsueh, Y., Meir, Y. J., Lai, J.-Y., Huang, C., Lu, T., Cheng, C.-M., Lin, S.-S., Ma, D. H.-K., & Wu, W.-C. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214719
Chen, L., Wu, J., Zhang, S., Huang, S., Xie, Y., Chen, H., Yang, Y., Xiao, L., Wang, D., Wu, K., et al. (2026) · BMEMat · doi:10.1002/bmm2.70076
Abu‐Amero, K. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146128
“Corneal epithelial, stromal and endothelial cell-derived exosomes have been shown to promote epithelial wound closure and enhance proliferation and migration by activating HSP27, STAT and beta-catenin signaling [40].”
Exosome-based therapies for corneal disorders: current status and future perspectives
Tang, N., Yin, X., Huang, A., Ma, J., Atala, A., & Zhang, Y. (2026) · MedScience · doi:10.1007/s11684-026-1225-z
Wu, Y., Zhang, M., Wu, H., Cai, M., Lin, S., Li, W. S., & Ou, S. (2026) · Eye & ENT Research · doi:10.1002/eer3.70055
Extracellular vesicles in ophthalmic diseases: current applications and future perspectives
Li, A., Yang, H., Liu, J., & 接英 (2026) · Scientia Sinica Vitae · doi:10.1360/ssv-2026-0244
Nerve Growth Factor Treatment and the Corneal Epithelium: Extracellular Vesicle‐Mediated Signaling
Kanu, L. N., Chatterjee, A., Mahmoud, M. Y., Yeung, V., Mudigunda, S. V., Ross, A. E., Hefley, B. S., Karamichos, D., & Ciolino, J. B. (2026) · Journal of Extracellular Biology · doi:10.1002/jex2.70192
Gao, N., Chen, Q., Stemmer, P. M., & Yu, F. X. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.08.009
Metadata
- Authors
- Desjardins, P., Berthiaume, R., Couture, C., Le-Bel, G., Roy, V., Gros-Louis, F., Moulin, V. J., Proulx, S., Chemtob, S., Germain, L., & Guérin, S. L.
- Affiliations
- Hôpital du Saint-Sacrement (CA)
- Regenerative Medicine Division of the Centre de Recherche du CHU de Québec, Université Laval, Québec, QC G1J 1Z4, Canada
- Hôpital de l'Enfant-Jésus (CA)
- Université de Montréal (CA)
- Corresponding author
- Guérin, Sylvain L.
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-10-13
- Volume
- 23
- Issue
- 20
- Pages
- 12201
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9602716
- OpenAlex
- W4306152285
- Cited by
- 39
- References
- 122
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 9 · 2023: 3 · 2022: 1
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science and Engineering Research Council of Canada ((NSERC; grant #RGPIN-2017-06123))
- Réseau de Recherche en Santé de la Vision from the FRQS ((NSERC; grant #RGPIN-2017-06123))
- studentships from the CIHR and the FRQS ((NSERC; grant #RGPIN-2017-06123))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Ophthalmology › Corneal Surgery and Treatments
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Keywords
- exosomes, corneal wound healing, corneal epithelial cells, corneal fibroblasts, corneal endothelial cells, extracellular vesicles, STAT signaling, p38 MAPK pathway, gene expression profiling, cell proliferation and migration, corneal wound closure
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Cell Movement, Cornea, Epithelial Cells, Humans, Wound Healing, Proteomics, Endothelial Cells, beta Catenin, Exosomes, HSP27 Heat-Shock Proteins, Corneal Injuries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.